Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Elizabeth Orr

Managing Editor, Policy & Regulation

Washington, DC

Elizabeth leads a small team of Medtech Insight reporters devoted to covering medical device and diagnostics regulation in the US and abroad. As a reporter, she focuses on FDA regulation, legislation, and legal issues. A graduate of the University of Maryland College Park, she worked for outlets including FDA News, DecisionHealth (formerly UCG) and the Washington Examiner before joining Pharma Intelligence in 2015. She lives in Arlington, VA, with her husband and children.

Latest From Elizabeth Orr

Eight Indicted In Alleged Genetic Testing Fraud

The eight had ties to a group of Tennessee labs that reportedly paid physicians to order medically unnecessary testing, billing Medicare more than $150m in five years.

Policy Legal Issues

Medtech Industry Mourns US Rep. Jackie Walorski

Indiana Republican Congresswoman Jackie Walorski, who died in a car crash Wednesday, was a strong proponent of device industry priorities such as device tax repeal and Medicare coverage for innovative technologies.

Politics Policy

Clinical Trials, Data Security Among US Federal Enforcement Priorities

Pandemic-related fraud, advertising to children, and corporate compliance programs are among the issues that were highlighted during a recent webinar.

Enforcement Legal Issues

Natural Cycles Fertility App Wins FDA Clearance For Oura Ring Integration

The app, the first to be approved with a birth control indication, can now sync data directly from the Oura Ring, a wearable device that tracks user’s biometrics.

Regulation Commercial

US Federal Enforcement Priorities Include Clinical Trials, Data Security

Speakers at a recent webinar laid out core priorities for federal agencies including the FDA and Department of Justice. Pandemic-related fraud, advertising to children, and corporate compliance programs are among the issues of note.

Policy Enforcement

Draft FDA Guidance Aims To Ensure Patients Understand LASIK Risks

The document would ask manufacturers to include additional plain-language labeling to ensure people considering LASIK have additional information about potential side effects and contraindications. 

Guidance Documents Regulation
See All